Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.

Last reported valuation

$31.7M

Oct 2026

Priced at

—

Total raised

$39.9M

Last round

Early Stage VC

Mar 2026

+ 3 more people (board, observers, advisors) · free account shows everyone

Membership and data by Private Market View

Who runs Sonire Therapeutics

3 people are listed on the Sonire Therapeutics team: 3 board members. 1 of them have a verified direct contact on file.

Free account

More of Sonire Therapeutics with a free account

·The complete investor list: 27 names
·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Contact database

Verified contact details, revealed on demand

1 of the people at Sonire Therapeutics have a verified contact on file. Plus members reveal 10 contacts a month, Pro members 200.

Unlock contact reveals

Membership and data by Private Market View